Summary
Chronic alcohol abuse leads to multiple defects in the immune system, leading to an increased risk of infectious disease and malignancy. Immune lesions encompass both the innate and adaptive arms and include deficiencies in the B-cell compartment. Long-term alcoholics exhibit loss of B cells in the periphery and diminished ability to generate protective antibodies. To better mimic the chronic alcoholic patient, our group has used an ethanol-in-drinking-water mouse model. Mice consuming alcohol in this manner progressively develop a range of immune abnormalities, including defects in humoral immunity. To document and explore B-cell lesions in ethanol-consuming mice, our laboratory has used a broad panel of technologies. These include protocols to define the physical state of B cells in the bone marrow and periphery, in vitro approaches to test B-cell activation potential and in vivo experiments to document the humoral competence of the host. These key techniques are detailed in the present chapter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
1. Sternbach, G. L. (1990) Infections in alcoholic patients. Emerg. Med. Clin. North Am. 8, 793–803.
2. MacGregor, R. R., and Louria, D. B. (1997) Alcohol and infection. Curr. Clin. Top. Infect. Dis. 17, 291–315.
3. Baker, R. C., and Jerrells, T. R. (1993) Recent developments in alcoholism: immunological aspects. Recent Dev. Alcohol. 11, 249–271.
4. Cook, R. T. (1998) Alcohol abuse, alcoholism, and damage to the immune system—a review. Alcohol. Clin. Exp. Res. 22, 1927–1942.
5. Szabo, G. (1999) Consequences of alcohol consumption on host defense. Alcohol Alcohol. 34, 830–841.
6. Nelson, S., and Kolls, J. K. (2002) Alcohol, host defense and society. Nat. Rev. Immunol. 2, 205–209.
7. Happel, K. I., and Nelson, S. (2005) Alcohol, immunosuppression, and the lung. Proc. Am. Thorac. Soc. 2, 428–432.
8. Ruiz, M., Ewig, S., Torres, A., Arancibia, F., Marco, F., Mensa, J., Sanchez, M., and Martinez, J. A. (1999) Severe community-acquired pneumonia. Risk factors and follow-up epidemiology. Am. J. Respir. Crit. Care. Med. 160, 923–929.
9. de Roux, A., Cavalcanti, M., Marcos, M. A., Garcia, E., Ewig, S., Mensa, J., and Torres, A. (2006) Impact of alcohol abuse in the etiology and severity of community-acquired pneumonia. Chest. 129, 1219–1225.
10. MacGregor, R. R. (1986) Alcohol and immune defense. JAMA. 256, 1474–1479.
11. Messingham, K. A., Faunce, D. E., and Kovacs, E. J. (2002) Alcohol, injury, and cellular immunity. Alcohol. 28, 137–149.
12. Cook, R. T., Waldschmidt, T. J., Ballas, Z. K., Cook, B. L., Booth, B. M., Stewart, B. C., and Garvey, M. J. (1994) Fine T-cell subsets in alcoholics as determined by the expression of L-selectin, leukocyte common antigen, and beta-integrin. Alcohol. Clin. Exp. Res. 18, 71–80.
13. Cook, R. T., Ballas, Z. K., Waldschmidt, T. J., Vandersteen, D., LaBrecque, D. R., and Cook, B. L. (1995) Modulation of T-cell adhesion markers, and the CD45R and CD57 antigens in human alcoholics. Alcohol. Clin. Exp. Res. 19, 555–563.
14. Song, K., Coleman, R. A., Alber, C., Ballas, Z. K., Waldschmidt, T. J., Mortari, F., LaBrecque, D. R., and Cook, R. T. (2001) TH1 cytokine response of CD57+ T-cell subsets in healthy controls and patients with alcoholic liver disease. Alcohol. 24, 155–167.
15. Laso, F. J., Madruga, J. I., Lopez, A., Ciudad, J., Alvarez-Mon, M., San Miguel, J., and Orfao, A. (1996) Distribution of peripheral blood lymphoid subsets in alcoholic liver cirrhosis: influence of ethanol intake. Alcohol. Clin. Exp. Res. 20, 1564–1568.
16. Mili, F., Flanders, W. D., Boring, J. R., Annest, J. L., and DeStefano, F. (1992) The associations of alcohol drinking and drinking cessation to measures of the immune system in middle-aged men. Alcohol. Clin. Exp. Res. 16, 688–694.
17. Cook, R. T., Waldschmidt, T. J., Cook, B. L., Labrecque, D. R., and McLatchie, K. (1996) Loss of the CD5+ and CD45RAhi B cell subsets in alcoholics. Clin. Exp. Immunol. 103, 304–310.
18. acanella, E., Estruch, R., Gaya, A., Fernandez-Sola, J., Antunez, E., and Urbano-Marquez, A. (1998) Activated lymphocytes (CD25+ CD69+ cells) and decreased CD19+ cells in well-nourished chronic alcoholics without ethanol-related diseases. Alcohol. Clin. Exp. Res. 22, 897–901.
19. Degos, F., Duhamel, G., Brechot, C., Nalpas, B., Courouce, A. M., Tron, F., and Berthelot, P. (1986) Hepatitis B vaccination in chronic alcoholics. J. Hepatol. 2, 402–409.
20. Mendenhall, C., Roselle, G. A., Lybecker, L. A., Marshall, L. E., Grossman, C. J., Myre, S. A., Weesner, R. E., and Morgan, D. D. (1988) Hepatitis B vaccination. Response of alcoholic with and without liver injury. Dig. Dis. Sci. 33, 263–269.
21. Nalpas, B., Thepot, V., Driss, F., Pol, S., Courouce, A. M., Saliou, P., and Berthelot, P. (1993) Secondary immune response to hepatitis B virus vaccine in alcoholics. Alcohol. Clin. Exp. Res. 17, 295–298.
22. Pillot, J., Poynard, T., Elias, A., Maillard, J., Lazizi, Y., Brancer, M., Dubreuil, P., Budkowska, A., and Chaput, J. C. (1995) Weak immunogenicity of the preS2 sequence and lack of circumventing effect on the unresponsiveness to the hepatitis B virus vaccine. Vaccine. 13, 289–294.
23. Johnson, R. D., and Williams, R. (1986) Immune responses in alcoholic liver disease. Alcohol. Clin. Exp. Res. 10, 471–486.
24. Smith, W. I., Jr., Van Thiel, D. H., Whiteside, T., Janoson, B., Magovern, J., Puet, T., and Rabin, B. S. (1980) Altered immunity in male patients with alcoholic liver disease: evidence for defective immune regulation. Alcohol. Clin. Exp. Res. 4, 199–206.
25. Drew, P. A., Clifton, P. M., LaBrooy, J. T., and Shearman, D. J. (1984) Polyclonal B cell activation in alcoholic patients with no evidence of liver dysfunction. Clin. Exp. Immunol. 57, 479–486.
26. Giron, J. A., Alvarez-Mon, M., Menendez-Caro, J. L., Abreu, L., Albillos, A., Manzano, L., and Durantez, A. (1992) Increased spontaneous and lymphokine-conditioned IgA and IgG synthesis by B cells from alcoholic cirrhotic patients. Hepatology. 16, 664–670.
27. Mishell, R. I., and Dutton, R. W. (1967) Immunization of dissociated spleen cell cultures from normal mice. J. Exp. Med. 126, 423–442.
28. Leptin, M., Potash, M. J., Grutzmann, R., Heusser, C., Shulman, M., Kohler, G., and Melchers, F. (1984) Monoclonal antibodies specific for murine IgM I. Characterization of antigenic determinants on the four constant domains of the mu heavy chain. Eur. J. Immunol. 14, 534–542.
29. Heath, A. W., Wu, W. W., and Howard, M. C. (1994) Monoclonal antibodies to murine CD40 define two distinct functional epitopes. Eur. J. Immunol. 24, 1828–1834.
30. Hardy, R. R., and Hayakawa, K. (2001) B cell development pathways. Annu. Rev. Immunol. 19, 595–621.
31. Thomas, M. D., Srivastava, B., and Allman, D. (2006) Regulation of peripheral B cell maturation. Cell Immunol. 239, 92–102.
32. Mebius, R. E., and Kraal, G. (2005) Structure and function of the spleen. Nat. Rev. Immunol. 5, 606–616.
33. Lyons, A. B., and Parish, C. R. (1994) Determination of lymphocyte division by flow cytometry. J. Immunol. Methods. 171, 131–137.
34. Hodgkin, P. D., Lee, J. H., and Lyons, A. B. (1996) B cell differentiation and isotype switching is related to division cycle number. J. Exp. Med. 184, 277–281.
35. Mower, D. A., Jr., Peckham, D. W., Illera, V. A., Fishbaugh, J. K., Stunz, L. L., and Ashman, R. F. (1994) Decreased membrane phospholipid packing and decreased cell size precede DNA cleavage in mature mouse B cell apoptosis. J. Immunol. 152, 4832–4842.
36. Erickson, L. D., Foy, T. M., and Waldschmidt, T. J. (2001) Murine B1 B cells require IL-5 for optimal T cell-dependent activation. J. Immunol. 166, 1531–1539.
37. Davis, H. L., Weeratna, R., Waldschmidt, T. J., Tygrett, L., Schorr, J., and Krieg, A. M. (1998) CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160, 870–876.
38. Gupta, R. K., Rost, B. E., Relyveld, E., and Siber, G. R. (1995) Adjuvant properties of aluminum and calcium compounds, in Vaccine Design: The Subunit and Adjuvant Approach (Powell, M. F., and Newman, M. J., eds.), Plenum Press, NY, pp. 229–248.
39. Rinella, J. V., Jr., White, J. L., and Hem, S. L. (1996) Treatment of aluminum hydroxide adjuvant to optimize the adsorption of basic proteins. Vaccine. 14, 298–300.
40. Weissburg, R. P., Berman, P. W., Cleland, J. L., Eastman, D., Farina, F., Frie, S., Lim, A., Mordenti, J., Nguyen, T. T., and Peterson, M. R. (1995) Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum. Pharm. Res. 12, 1439–1446.
41. Kelsoe, G. (1995) In situ studies of the germinal center reaction. Adv. Immunol. 60, 267–288.
42. Wolniak, K. L., Shinall, S. M., and Waldschmidt, T. J. (2004). The germinal center response. Crit. Rev. Immunol. 24: 39–65.
43. Hayakawa, K., Ishii, R., Yamasaki, K., Kishimoto, T., and Hardy, R. R. (1987) Isolation of high-affinity memory B cells: Phycoerythrin as a probe for antigen-binding cells. Proc. Natl. Acad. Sci. USA. 84, 1379–1383.
Acknowledgments
The authors wish to thank Ms Teresa Duling for expert help with flow cytometry. This work was supported by RO1 AA014400.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Verma, S., Alexander, CM.A., Carlson, M.J., Tygrett, L.T., Waldschmidt, T.J. (2008). B-Cell Studies in Chronic Ethanol Mice. In: Nagy, L.E. (eds) Alcohol. Methods in Molecular Biology™, vol 447. Humana Press. https://doi.org/10.1007/978-1-59745-242-7_20
Download citation
DOI: https://doi.org/10.1007/978-1-59745-242-7_20
Publisher Name: Humana Press
Print ISBN: 978-1-58829-906-2
Online ISBN: 978-1-59745-242-7
eBook Packages: Springer Protocols